Okay let me reposition my concerns. Why has PAR communicated 3 different dates for P3 Pivotal since CR in Oct 23?
At this stage of the game should PR and his team not be more on top of the required clinical details? I've previously made the observation there was 0% chance of them sticking to any deadline disclosed in any preso in 2023. And no indicative date will come in!!!!
PAR. SP, page-651
-
- There are more pages in this discussion • 501 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $85.35K | 365.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 280011 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 44703 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |